BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 8166452)

  • 1. Gastrin receptor gene expression in several human carcinomas.
    Matsushima Y; Kinoshita Y; Nakata H; Inomoto-Naribayashi Y; Asahara M; Kawanami C; Nakamura A; Ito M; Matsui T; Fujiwara T
    Jpn J Cancer Res; 1994 Aug; 85(8):819-24. PubMed ID: 7928627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.
    Copps J; Murphy RF; Lovas S
    Protein Pept Lett; 2009; 16(12):1504-18. PubMed ID: 20001914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of bioactive analogs of the N-terminal region of gastrin-17.
    Copps J; Murphy RF; Lovas S
    Peptides; 2009 Dec; 30(12):2250-62. PubMed ID: 19766682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactivity of analogs of the N-terminal region of gastrin-17.
    Copps J; Ahmed S; Murphy RF; Lovas S
    Peptides; 2009 Dec; 30(12):2263-7. PubMed ID: 19761808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production.
    Colucci R; Blandizzi C; Tanini M; Vassalle C; Breschi MC; Del Tacca M
    Br J Pharmacol; 2005 Feb; 144(3):338-48. PubMed ID: 15655524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory effect and mechanism of gastrin and its antagonists on colorectal carcinoma.
    He SW; Shen KQ; He YJ; Xie B; Zhao YM
    World J Gastroenterol; 1999 Oct; 5(5):408-416. PubMed ID: 11819478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic agents directed to peptide hormone receptors: defining the requirements for a successful drug.
    Czerwinski G; Tarasova NI; Michejda CJ
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11520-5. PubMed ID: 9751698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrin antagonists in the treatment of gastric cancer.
    Watson SA; Steele RJ
    Anticancer Drugs; 1993 Dec; 4(6):599-604. PubMed ID: 8298161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gastrin, proglumide, loxiglumide and L-365,260 on growth of human colon carcinoma cells.
    Mauss S; Niederau C; Hengels KJ
    Anticancer Res; 1994; 14(1A):215-20. PubMed ID: 8166452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential mode of action of high- and low-affinity CCK/gastrin receptor antagonists in growth inhibition of gastrin--responsive human gastric adenocarcinoma cells in vitro.
    Piontek MK; Hengels KJ
    Anticancer Res; 1993; 13(3):715-20. PubMed ID: 8317902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine growth stimulation of human renal Wilms' tumour G401 cells by a gastrin-like peptide.
    Blackmore M; Doherty E; Manning JE; Hirst BH
    Int J Cancer; 1994 May; 57(3):385-91. PubMed ID: 8169000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines.
    Hoosein NM; Kiener PA; Curry RC; Rovati LC; McGilbra DK; Brattain MG
    Cancer Res; 1988 Dec; 48(24 Pt 1):7179-83. PubMed ID: 3191491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for autocrine growth stimulation by a gastrin/CCK-like peptide of the gastric cancer HGT-1 cell line.
    Remy-Heintz N; Perrier-Meissonnier S; Nonotte I; Laliberté MF; Chevillard C; Laboisse C; Bali JP
    Mol Cell Endocrinol; 1993 May; 93(1):23-9. PubMed ID: 8319831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumide.
    Watson SA; Morris DL; Durrant LG; Robertson JF; Hardcastle JD
    Eur J Cancer; 1992; 28A(8-9):1462-7. PubMed ID: 1355350
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.